Literature DB >> 8388692

Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis.

D R Jayne1, V L Esnault, C M Lockwood.   

Abstract

The presence of anti-idiotype antibody (anti-id) activity to anti-myeloperoxidase autoantibodies (anti-MPO) was measured by assessing binding of IgG in patients' sera to F(ab')2 fragments of polyclonal heterologous anti-MPO antiserum. Thirteen paired acute and remission sera and three groups of sequential sera from patients with systemic vasculitis were studied. The levels of anti-MPO fell as disease activity subsided with treatment. However, levels of anti-id activity against these anti-MPO rose as patients entered remission. This effect was still seen after controlling for binding to F(ab')2 constant regions and after polyethylene glycol precipitation of immune complexes. In the sequential studies, levels of anti-MPO and anti-MPO anti-id tended towards a reciprocal relationship. These observations point to dynamic interactions between autoantibody and complementary anti-idiotype antibodies in this system and a role for idiotypic networks in the regulation of anti-neutrophil cytoplasm antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388692     DOI: 10.1006/jaut.1993.1019

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  7 in total

Review 1.  Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.

Authors:  Christiane S Hampe
Journal:  Autoimmunity       Date:  2012-02-23       Impact factor: 2.815

2.  Anti-idiotype antibodies in immune regulation of anca associated vasculitis.

Authors:  Vandana D Pradhan; Kanjaksha Ghosh
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

3.  Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies.

Authors:  Tyler R Hall; Marika Bogdani; Renee C Leboeuf; Elizabeth A Kirk; Marlena Maziarz; J Paul Banga; Shilpa Oak; Christina A Pennington; Christiane S Hampe
Journal:  Immunology       Date:  2007-11-14       Impact factor: 7.397

Review 4.  Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Richard W Lee; David P D'Cruz
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients.

Authors:  M Nardi; S Karpatkin
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

6.  Mimicry of human IgE epitopes by anti-idiotypic antibodies.

Authors:  M Vogel; S Miescher; S Kuhn; A W Zürcher; M B Stadler; C Ruf; F Effenberger; F Kricek; B M Stadler
Journal:  J Mol Biol       Date:  2000-05-19       Impact factor: 5.469

7.  Structural basis for the recognition in an idiotype-anti-idiotype antibody complex related to celiac disease.

Authors:  Anna Vangone; Safwat Abdel-Azeim; Ivana Caputo; Daniele Sblattero; Roberto Di Niro; Luigi Cavallo; Romina Oliva
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.